Author:
Yamasoba Daichi,Uriu Keiya,Plianchaisuk Arnon,Kosugi Yusuke,Pan Lin,Zahradnik Jiri,Ito Jumpei,Sato Kei
Reference3 articles.
1. SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution;Zahradnik;Nat Microbiol,2021
2. Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two omicron subvariants;Tamura;bioRxiv,2022
3. Mapping the antigenic and genetic evolution of influenza virus;Smith;Science,2004